CAH
Price
$103.20
Change
-$0.61 (-0.59%)
Updated
Apr 26, 6:59 PM EST
4 days until earnings call
PDCO
Price
$25.77
Change
-$0.03 (-0.12%)
Updated
Apr 26, 6:59 PM EST
52 days until earnings call
Ad is loading...

Compare predictions CAH vs PDCO

Header iconCAH vs PDCO Comparison
Open Charts CAH vs PDCOBanner chart's image
Cardinal Health
Price$103.20
Change-$0.61 (-0.59%)
Volume$340.56K
CapitalizationN/A
Patterson Companies
Price$25.77
Change-$0.03 (-0.12%)
Volume$268.58K
CapitalizationN/A
View a ticker or compare two or three
CAH vs PDCO Comparison Chart

Loading...

CAHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PDCODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CAH vs. PDCO commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Hold and PDCO is a Hold.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (CAH: $103.21 vs. PDCO: $25.77)
Brand notoriety: CAH and PDCO are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 62% vs. PDCO: 60%
Market capitalization -- CAH: $27.26B vs. PDCO: $2.48B
CAH [@Medical Distributors] is valued at $27.26B. PDCO’s [@Medical Distributors] market capitalization is $2.48B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 1 FA rating(s) are green whilePDCO’s FA Score has 1 green FA rating(s).

  • CAH’s FA Score: 1 green, 4 red.
  • PDCO’s FA Score: 1 green, 4 red.
According to our system of comparison, PDCO is a better buy in the long-term than CAH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 4 TA indicator(s) are bullish while PDCO’s TA Score has 5 bullish TA indicator(s).

  • CAH’s TA Score: 4 bullish, 5 bearish.
  • PDCO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, PDCO is a better buy in the short-term than CAH.

Price Growth

CAH (@Medical Distributors) experienced а -4.60% price change this week, while PDCO (@Medical Distributors) price change was -0.96% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +9.34%. For the same industry, the average monthly price growth was +4.58%, and the average quarterly price growth was +5.45%.

Reported Earning Dates

CAH is expected to report earnings on Aug 08, 2024.

PDCO is expected to report earnings on Jun 19, 2024.

Industries' Descriptions

@Medical Distributors (+9.34% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
A.I.dvisor published
a Summary for CAH with price predictions.
OPEN
A.I.dvisor published
a Summary for PDCO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CAH($27.3B) has a higher market cap than PDCO($2.48B). CAH has higher P/E ratio than PDCO: CAH (44.47) vs PDCO (13.32). CAH YTD gains are higher at: 2.848 vs. PDCO (-8.621). CAH has higher annual earnings (EBITDA): 1.89B vs. PDCO (384M). CAH has more cash in the bank: 4.59B vs. PDCO (124M). PDCO has less debt than CAH: PDCO (895M) vs CAH (4.72B). CAH has higher revenues than PDCO: CAH (216B) vs PDCO (6.57B).
CAHPDCOCAH / PDCO
Capitalization27.3B2.48B1,102%
EBITDA1.89B384M493%
Gain YTD2.848-8.621-33%
P/E Ratio44.4713.32334%
Revenue216B6.57B3,289%
Total Cash4.59B124M3,702%
Total Debt4.72B895M528%
FUNDAMENTALS RATINGS
CAH vs PDCO: Fundamental Ratings
CAH
PDCO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
340
SMR RATING
1..100
9950
PRICE GROWTH RATING
1..100
5276
P/E GROWTH RATING
1..100
7363
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDCO's Valuation (30) in the Medical Distributors industry is somewhat better than the same rating for CAH (79). This means that PDCO’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Profit vs Risk Rating (3) in the Medical Distributors industry is somewhat better than the same rating for PDCO (40). This means that CAH’s stock grew somewhat faster than PDCO’s over the last 12 months.

PDCO's SMR Rating (50) in the Medical Distributors industry is somewhat better than the same rating for CAH (99). This means that PDCO’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Price Growth Rating (52) in the Medical Distributors industry is in the same range as PDCO (76). This means that CAH’s stock grew similarly to PDCO’s over the last 12 months.

PDCO's P/E Growth Rating (63) in the Medical Distributors industry is in the same range as CAH (73). This means that PDCO’s stock grew similarly to CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHPDCO
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
40%
Bullish Trend 3 days ago
63%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
40%
Bearish Trend 3 days ago
55%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 11 days ago
50%
Bearish Trend 3 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
65%
Aroon
ODDS (%)
Bearish Trend 3 days ago
46%
N/A
View a ticker or compare two or three
Ad is loading...
CAHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PDCODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRBK55.591.13
+2.07%
Green Brick Partners
NYMT7.040.07
+1.00%
New York Mortgage Trust
YS0.80N/A
+0.63%
YS Biopharma Co Ltd
NBIX135.99-1.77
-1.28%
Neurocrine Biosciences
AYRO1.41-0.05
-3.42%
AYRO

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
-0.58%
COR - CAH
62%
Loosely correlated
+0.47%
MCK - CAH
59%
Loosely correlated
+0.62%
OMI - CAH
29%
Poorly correlated
+4.02%
PDCO - CAH
15%
Poorly correlated
-0.12%
HSIC - CAH
13%
Poorly correlated
+0.43%
More

PDCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDCO has been loosely correlated with HSIC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PDCO jumps, then HSIC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDCO
1D Price
Change %
PDCO100%
-0.12%
HSIC - PDCO
46%
Loosely correlated
+0.43%
OMI - PDCO
20%
Poorly correlated
+4.02%
CAH - PDCO
18%
Poorly correlated
-0.58%
COR - PDCO
16%
Poorly correlated
+0.47%
ZYXI - PDCO
13%
Poorly correlated
+2.47%
More